My doctor told me about the OPTION clinical trial and suggested that I consider a Watchman device. Can you comment on OPTION, ...

My doctor told me about the OPTION clinical trial and suggested that I consider a WATCHMAN device. Can you comment ... blood clots originate in the left atrial appendage (LAA).

In NVAF, blood clots can form in a part of the heart called the left atrial appendage (LAA). The Watchman device closes off the LAA and prevents blood clots from leaving the heart. While blood ...

A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have ...

My doctor told me about the OPTION clinical trial and suggested that I consider a WATCHMAN device. Can you comment ... blood clots originate in the left atrial appendage (LAA).

ODESSA, Texas (KMID/KPEJ) – Dr. Manohar Angirekula, Dr. Adam Farber, and Dr. Fernando Boccalandro have successfully implanted the first “Watchman FLX” Pro Device at Medical Center Hospital.

According to Boston Scientific, maker of the WATCHMAN device, Dr. Eckart has implanted ... thinning medications – by sealing off the left atrial appendage (LAA) in the heart.

The WATCHMAN device is a tiny implant that closes off an area of the heart called the left atrial appendage to keep harmful blood clots from entering the blood stream and potentially causing a stroke.

My doctor told me about the OPTION clinical trial and suggested that I consider a WATCHMAN device. Can you comment ... blood clots originate in the left atrial appendage (LAA).

I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in ...